Inflammatory Bowel Disease and Osteoporosis

References

• Consensus development conference: diagnosis, prophylaxis and treament of osteoporosis. Am J Med 1994; 645–50, Anonymous
   PubMed Web of Science ®Google Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO, Geneva 1994, Report of a WHO study group WHO technical report series 843
   Google Scholar
• Manolagas S. C., Jilka R. L. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995; 332: 305–11
   PubMed Web of Science ®Google Scholar
• Rungby J., Hermann A. P., Mosekilde L. Epidemiology of osteoporosis. Drugs Aging 1995; 6: 470–8
   PubMed Web of Science ®Google Scholar
• Kanis J. A., McCloskey E. V. Epidemiology of vertebral osteoporosis. Bone 1992; 13: 81–10
   PubMed Web of Science ®Google Scholar
• Chapuy M. C., Arlot M. E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3 and calcium to prevent hip fractures in the elderly. N Engl J Med 1992; 327: 1637–42
   PubMed Web of Science ®Google Scholar
• Cooper C., Atkinson E. J., O'Fallon W., Melton L. J., III. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7: 221–7
   PubMed Web of Science ®Google Scholar
• Ross P. D., Davis J. W., Epstein R. S., Wasnich R. D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919–23
   PubMed Web of Science ®Google Scholar
• Kotowicz M. A., Melton L. J., Cooper C., Atkinson E. J., O'Fallon W. M., Riggs L. B. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 1994; 9: 599–605
   PubMed Web of Science ®Google Scholar
• Gardsell P., Johnell O., Nilsson B. E., Nilsson J. Å. The predictive value of fracture, disease and falling tendency for fragility fractures in women. Calcif Tissue Tnt 1989; 45: 327–30
   PubMed Web of Science ®Google Scholar
• Melton L. J., Atkinson E. J., O'Fallon W. M., Warmer H. W., Riggs L. B. Long-term fracture prediction by bone mineral assessment at different skeletal sites. J Bone Miner Res 1993; 8: 1227–33
   PubMed Web of Science ®Google Scholar
• Gardsell P., Johnell O., Nilsson B. E., Gullberg B. Predicting various fragility fractures in women by forearm densitometry: a follow-up study. Calcif Tissue Int 1993; 52: 348–58
   PubMed Web of Science ®Google Scholar
• Cummings S. R., Black D. M., Nevitl M. C., Browner W., Cauley J., Ensrud K., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341: 72–5
   PubMed Web of Science ®Google Scholar
• Rigeaud D., Angel L. A., Cerf M., Carduner M. J., Melchior J., Santier C., et al. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 1994; 60: 775–81
   PubMed Web of Science ®Google Scholar
• Vogelsang H., Klamert M., Resch H., Ferrenci P. Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr 1995; 107: 578–81
   PubMed Web of Science ®Google Scholar
• Silvennoinen J., Lamberg-Allardt C., Kärkäinen M., Niemelä S., Lehtola J. Dietary calcium intake and its relation to bone mineral density in patients with inflammatary bowel disease. J Immunol Methods 1996; 240: 285–92
   Google Scholar
• Imes S., Pinchbeck B. R., Thomson A. B. Diet counseling modifies nutrient intake ofptients with Crohn's disease. J Am Diet Assoc 1987; 87: 457–62
   PubMedGoogle Scholar
• Felson D. T., Zhang Y., Hannan M. T., Anderson J. J. Effects of weight and body mass index on bone mineral density in men and women: the Framingham Study. J Bone Miner Res 1993; 567–73, Suppl
   PubMedGoogle Scholar
• Reid D. M. Corticosteroid-induced osteoporosis. Osteoporosis 1990, R. Smith. Royal College of Physicians of London, London 1990; 99–117
   Google Scholar
• Thibaud D., Krige M. A., Gillard-Berguer D., Jacquet A. F., Goy J. J., Burchardt P. Cyclosporine induces high bone turnover and may constitiute to bone loss after heart transplantation. Eur J Clin Invest 1996; 26: 549–55
   PubMed Web of Science ®Google Scholar
• Hay J. E., Lindor K. D., Wiesner R. H., Dickson E. R., Krom R. A F, Larusso N. F. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991; 14: 257–61
   PubMed Web of Science ®Google Scholar
• MacDonald B. R., Gowen M. Cytokines and bone. Br J Rheumatol 1992; 31: 149–55
   PubMedGoogle Scholar
• Silvennoinen J. A., Lethola J. K., Niemelä S. E. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996; 31: 367–71
   PubMed Web of Science ®Google Scholar
• Goldstein M. J., Gelzayd E. A., Kirsner J. B. Some observations on the hazards of corticosteroid therapy in patients with inflammatory bowel disease. Trans Am Acad Ophth Otol 1967; 254–61
   PubMedGoogle Scholar
• Genant H. K., Mall J. C., Wagonfeld J. B., Horst J. V., Lanzl L. H. Skeletal demineralization and growth retardation in inflammatory bowel disease. Invest Rad 1977; 541–9
   Web of Science ®Google Scholar
• Grecnstein A. J., Janowitz Sachar D. B. The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55: 401–12
   PubMed Web of Science ®Google Scholar
• Neef B., Höring E., Maier K.-E. Gaisberg U. v. Schwere osteoporose bei einer jungen Patientin mit Morbus Crohn. Dtsch Med Wochenschr 1991; 116: 1055–60
   PubMedGoogle Scholar
• Cowan F. J., Parker D. R., Jenkins H. R. Osteopenia in Crohn's disease. Arch Dis Child 1995; 7: 255–6
   Google Scholar
• Cowan F. J., Warner J. T., Dunstan F. D J, Evans W. D., Gregory J. W., Jenkins H. R R. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997; 76: 325–9
   PubMed Web of Science ®Google Scholar
• Teufel M., Meyer-Hohnloser K., Mörcke E. M., Stubig U., Niessen K. H. Nachuntersuchungen bei 60 kinder mit Colitis Ulcerosa und Morbus Crohn. Monalsschr Kinderheikd 1988; 136: 378–83
   PubMedGoogle Scholar
• Hylander E., Ladefoged K., Madsen S. Calcium balance and bone mineral content after small intestinal resection. Scand J Gastroenterol 1981; 16: 167–76
   PubMed Web of Science ®Google Scholar
• Vogelsang H., Ferenci P., Woloszczuk W., Resch H., Herold C., Frotz S., et al. Bone disease in vitamin D deficient patients with Crohn's disease. Dig Dis Sci 1989; 34: 1094–99
   PubMed Web of Science ®Google Scholar
• Compston J. E., Judd D., Crawley E. O., Evans W. D., Evans C., Church H. A., et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410–5
   PubMed Web of Science ®Google Scholar
• Pigot F., Roux C., Chaussade S., Hardelin D., Pilleter O., de Puy Montbrun T., et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37: 1396–403
   PubMed Web of Science ®Google Scholar
• Tromm A., Rickels K., Hüppe D., Wiebe V., May B. Osteopenie bei chronish entzündtliehen darmkrankungen. Leber Magen Darm 1994; 24: 23–30
   PubMedGoogle Scholar
• Scarla S. H., Minne H. W., Lempert U. G., Leidig G., Hauber M., Raedseh T., et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel diseases (Crohn's disease and colitis ulcerosa). Exp Clin Endocrinol 1994; 102: 44–9
   PubMedGoogle Scholar
• Ghosh S., Cowen S., Hannan W. J., Ferguson A. Low bone mineral density in Crohn's disease but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031–9
   PubMed Web of Science ®Google Scholar
• Abitbol V., Roux C., Chaussade S., Guillemant S., Kolta S., Dougados M., et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417–22
   PubMed Web of Science ®Google Scholar
• Bernstein C. N., Seeger L. L., Sayre J. W., Anton P. A., Artinian L., Shanahan F. Decreased bone density in inflammatory bowel dsease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995; 10: 250–6
   PubMed Web of Science ®Google Scholar
• Silvennoinen J. A., Karttunen T. J., Niemelä S. E., Manclius J. J., Lehtola J. K. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37: 71–6
   PubMed Web of Science ®Google Scholar
• Andreassen H., Rix M., Hylander E. Osteoporosis in a Danish out-patient clinic: bone mineral measurements and biochemical markers [abstract 956]. Gut 1996; 39(Suppl 3)168A
   Google Scholar
• Bjarnason I., Macpherson A., Mackintosh C., Buxton-Thomas M., Forgacs I., Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 228–33
   PubMed Web of Science ®Google Scholar
• Jahnsen J., Falch J. A., Aadland E., Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 313–9
   PubMed Web of Science ®Google Scholar
• Motley R. J., Crawley E. O., Evans C., Rhodes J., Compston J. E. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988; 29: 1332–6
   PubMed Web of Science ®Google Scholar
• Ryde S. J S, Clements D., Evans W. D., Motley T., Morgan W. D., Evans C., et al. Total body calcium in patients with inflammatory bowel disease: a longitudinal study. Clin Sci 1991; 80: 319–24
   Web of Science ®Google Scholar
• Clements D., Motley R. J., Evans W. D., Harries A. D., Rhodes J., Coles R. J., et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992; 27: 1055–60
   PubMed Web of Science ®Google Scholar
• Roux C., Abitbol V., Chaussade S., Kolta S., Guillemant S., Dougados M., et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporosis Int 1995; 5: 156–60
   PubMed Web of Science ®Google Scholar
• Motley R. J., Clements D., Evans W. D., Crawley E. O., Evans C., Rhodes J., et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993; 23: 95–104
   PubMedGoogle Scholar
• Staun M., Tjellesen L., Thale M., Schaadt O., Jamum S. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997; 32: 226–32
   PubMed Web of Science ®Google Scholar
• Compston J. E., Horton L. W L, Ayers A. B., Tighc J. R. Osteomalacia after small-bowel resection. Lancet 1978; 1: 9–12
   PubMed Web of Science ®Google Scholar
• Driscoll R. H., Meredith S. C., Sitrin M., Rosenberg I. H. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982; 83: 1252–8
   PubMed Web of Science ®Google Scholar
• Hessov L., Mosekilde L., Melsen F., Fadth S., Hulten L., Lund B., et al. Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease. Scand J Gastroenterol 1984; 19: 691–6
   PubMed Web of Science ®Google Scholar
• Croucher P. I., Vedi S., Motley R. J., Garrahan J. N., Stanton M. R., Compston J. E. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993; 3: 236–41
   PubMed Web of Science ®Google Scholar
• Silvenoinnen J., Risteli L., Karttunen T., Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut, 38: 223–8
   PubMed Web of Science ®Google Scholar
• Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrin Metab, 81: 3441–7
   PubMed Web of Science ®Google Scholar
• Sonnenberg A., Ehms H., Sonnenberg G. E., Strohmeyer G. 25-hydroxy-cholecalciferol serum levels in patients with Crohn's disease. Acta Hepatogastroenterol 1977; 24: 293–5
   PubMedGoogle Scholar
• Compston J. E., Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 1977; 18: 171–5
   PubMed Web of Science ®Google Scholar
• Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Int Med 1996; 239: 131–7
   PubMed Web of Science ®Google Scholar
• Clements D., Compston J. E., Evans W. D., Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993; 34: 1543–6
   PubMed Web of Science ®Google Scholar
• Vogelsang H. Prevention of bone mineral loss in patients with Crohn's disease by longterm oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995; 7: 609–14
   PubMed Web of Science ®Google Scholar
• Sandström B., Aro A., Becker W., Lyhne N., Pedersen J. I., Pórsdottir I. Nordiska näringsrekommendationer 1996. Nord 1996. Nordiske Ministerråd, Copenhagen 1996
   Google Scholar
• Rutgeerts P., Løfberg R., Malchow H., Lamers C., Olaison G., Jewell D., et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842–5
   PubMed Web of Science ®Google Scholar
• Greenberg G., Feagan B., Martin F., Sutherlan L. R., Thompson A. B R, Williams N. C., et al. Oral budesonide for the treatment of active Crohn's disease. N Engl J Med 1994; 331: 836–41
   PubMed Web of Science ®Google Scholar